ARCHIVES

LabCorp Marketing Of Ovarian Cancer Test Unlawful, FDA Says In Warning Letter.

This article is from The Cancer Letter archive.

Vol. 34 No. 38 | October 17, 2008

Download PDF Visit The Full Archive

Related Articles

AACI Asks NCI to Reconsider Dropping CCPDS Support, Find New Mechanism to Fund Center Outreach Effort

July 9, 1982

FDA News: ODAC Clears Photofrin For Microinvasive NSCLC

September 26, 1997

Afinitor Suspension Approved For Rare Pediatric Brain Tumor

August 31, 2012

Gallo Breakthrough On AIDS Etiology To Be Reported Soon

April 20, 1984

Weinberger, Edwards Back Away From Fight Over NCI’s Independence, Ask For Authorization Figures To Be Dropped

February 8, 1974

Block, Committee Agree; No New PDQ For General Public

January 11, 1985